| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 545 | 1.167 | 5.537 | 4.929 | 8.400 | 4.164 | 468 | 0 |
| Total Income - EUR | - | - | 545 | 1.167 | 5.537 | 4.929 | 8.665 | 4.407 | 710 | 241 |
| Total Expenses - EUR | - | - | 214 | 40 | 1.143 | 280 | 374 | 807 | 1.316 | 241 |
| Gross Profit/Loss - EUR | - | - | 331 | 1.126 | 4.394 | 4.649 | 8.291 | 3.600 | -607 | 0 |
| Net Profit/Loss - EUR | - | - | 315 | 1.091 | 4.233 | 4.530 | 8.067 | 3.499 | -607 | 0 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermtim Evolution Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 1.980 | 1.694 | 1.457 | 1.210 | 963 |
| Current Assets | - | - | 375 | 1.463 | 4.306 | 4.627 | 8.163 | 5.571 | 4.931 | 4.903 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.042 | 1.022 | 562 | 6.824 | 4.724 | 4.782 | 4.755 |
| Cash | - | - | 375 | 421 | 3.284 | 4.065 | 1.338 | 847 | 149 | 148 |
| Shareholders Funds | - | - | 359 | 1.443 | 4.284 | 4.580 | 8.116 | 5.557 | 4.934 | 4.906 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 16 | 20 | 22 | 26 | 49 | 16 | 0 | 0 |
| Income in Advance | - | - | 0 | 0 | 0 | 2.001 | 1.692 | 1.454 | 1.208 | 960 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermtim Evolution Srl